X0609 4 2026-06-30 false 0001716166 Vivos Therapeutics, Inc. VVOS 0002074003 Skaff Michael C false 18000 MACK AVE GROSSE POINTE MI 48230 false false true false false Series A Convertible Preferred Stock 0.456 2026-06-30 4 P false 859166 0.582 A Common Stock 859166 859166 I By V-Co Investors 4 LLC Series A Convertible Preferred Stock 0.456 2026-06-30 4 P false 1890164 0.582 A Common Stock 1890164 2749330 I By V-Co Investors 4 LLC Common Stock Purchase Warrant 0.456 2026-06-30 4 P false 2749330 0.582 A 2026-06-30 2031-06-30 Common Stock 2749330 2749330 I By V-Co Investors 4 LLC The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date. Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. On June 30, 2026, V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000 entered into between the reporting person and the Issuer into shares of the Issuer's Series A Convertible Preferred Stock, based on $0.456 per share plus $0.125 per share in accordance with the Nasdaq minimum price rules. /s/ Michael C. Skaff, as Managing Director SP Manager LLC, Manager of V-Co Investors 4 LLC 2026-07-13 /s/ Michael C. Skaff, as Individual 2026-07-15